34.45
前日終値:
$33.93
開ける:
$33.93
24時間の取引高:
206.58K
Relative Volume:
0.85
時価総額:
$1.40B
収益:
$1.50B
当期純損益:
$95.23M
株価収益率:
14.80
EPS:
2.328
ネットキャッシュフロー:
$12.77M
1週間 パフォーマンス:
-0.32%
1か月 パフォーマンス:
-4.12%
6か月 パフォーマンス:
-39.57%
1年 パフォーマンス:
-9.44%
Phibro Animal Health Corp Stock (PAHC) Company Profile
名前
Phibro Animal Health Corp
セクター
電話
201-329-7300
住所
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, TEVA, HLN, ZTS, VTRS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp
|
34.45 | 1.40B | 1.50B | 95.23M | 12.77M | 2.328 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Citigroup | Neutral |
| 2025-07-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-06-16 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | 開始されました | JP Morgan | Neutral |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Underperform |
| 2022-12-21 | 開始されました | ROTH Capital | Buy |
| 2022-07-25 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-01-10 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-11-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-08-05 | 再開されました | Credit Suisse | Neutral |
| 2021-07-07 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2020-08-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2020-01-28 | アップグレード | Barclays | Underweight → Equal Weight |
| 2019-09-05 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | 繰り返されました | BofA/Merrill | Underperform |
| 2019-06-11 | 開始されました | Barclays | Underweight |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-05-09 | アップグレード | Gabelli & Co | Hold → Buy |
| 2017-08-23 | 再開されました | BofA/Merrill | Underperform |
| 2017-06-02 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | 開始されました | Piper Jaffray | Overweight |
| 2016-11-11 | ダウングレード | Macquarie | Neutral → Underperform |
| 2016-11-10 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2016-04-11 | 繰り返されました | Guggenheim | Buy |
| 2016-02-04 | 開始されました | Credit Suisse | Outperform |
| 2016-01-15 | ダウングレード | Barclays | Overweight → Underweight |
| 2015-09-30 | 開始されました | Gabelli & Co | Buy |
| 2015-04-24 | 繰り返されました | Barclays | Overweight |
| 2015-04-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | 開始されました | Barclays | Overweight |
すべてを表示
Phibro Animal Health Corp (PAHC) 最新ニュース
Phibro Animal Health Corporation (PAHC) stock price, news, quote and history - Yahoo Finance Singapore
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report? - Yahoo Finance
Phibro Animal Health Corporation (PAHC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo Finance
Branded Pharmaceuticals Stocks Q2 In Review: Phibro Animal Health (NASDAQ:PAHC) Vs Peers - Yahoo Finance
Phibro Animal Health CFO David Glenn Granted 3,482 Shares, Increasing Holdings to 54,959 - Kalkine Media
Phibro Animal Health Corp Grants COO Miller Larry Lee 3,726 Shares, Increasing His Stake to 38,275 - Kalkine Media
Phibro Animal Health (PAHC) updates CFO’s 3,482-unit stock grant - Stock Titan
COO stock award takes Phibro Animal Health (PAHC) stake to 38,275 units - Stock Titan
Zacks.com featured highlights DiamondRock, Vertiv, Mueller Water Products and Phibro - Yahoo Finance
Big Phibro Animal Health (PAHC) investor lines up stock sale plan - Stock Titan
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect? - finance.yahoo.com
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Yahoo Finance
Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.9% -- What GF Sc - GuruFocus
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Understanding Phibro (PAHC) Reliance on International Revenue - Yahoo Finance
Phibro Animal Health Corporation Class A (PAHC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Teleconferência de Resultados do 4º Trimestre Fiscal e do Ano Fiscal de 2026 da PAHC: Crescimento das Vendas, Guidance para 2027 e Risco Brasil - TradingKey
PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds - Yahoo Finance
Phibro Animal Health declares $0.12 quarterly dividend - scanx.trade
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates - Investing.com
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates By Investing.com - Investing.com India
PAHC SWOT Analysis: Strong Growth Potential Amidst Valuation Con - GuruFocus
Is Phibro Animal Health Corp (PAHC) Overvalued After Q4 Earnings - GuruFocus
Phibro Animal Health Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026 - Kalkine Media
(PAHC) Phibro Animal Health Expects Fiscal 2027 Revenue Range $1.55B$1.60B, vs. FactSet Est of $1.55B - marketscreener.com
Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, vs. FactSet Est of $381.2M - marketscreener.com
Phibro Animal Health Corporation (PAHC) Stock Rises on Q4 2026 Earnings - Quiver Quantitative
Phibro Animal Health jumps 5% on strong Q4 earnings and guidance beat - Investing.com
PHIBRO ANIMAL HEALTH CORP FY 2026: Revenue $1.52B, EPS $2.43— 10-K Summary - TradingView
Phibro: Fiscal Q4 Earnings Snapshot - KVUE
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Yahoo Finance
Phibro Animal Health sets FY27 adj EPS $3.41-$3.59, beats est - scanx.trade
JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Nigeria
Earnings To Watch: Phibro Animal Health (PAHC) Reports Q2 Results Tomorrow - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.2% -- What GF Sc - GuruFocus
Phibro (PAHC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Is Phibro Animal Health (PAHC) Still Reasonable After A 149% Run? - Yahoo Finance
Phibro Animal Health (PAHC) Could Be 22% Undervalued On Upcoming Earnings - Yahoo Finance
Phibro Animal Health to report Q4 FY26 results on August 26 - scanx.trade
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results - Yahoo Finance Singapore
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Shares Cross Below 200 Day Moving AverageHere's What Happened - marketbeat.com
Phibro Animal Health (PAHC) Stock Looks Undervalued On Earnings Yet Mixed Elsewhere - simplywall.st
All News for PAHC : Phibro Animal Health - Zacks Investment Research
Phibro Animal Health Corp (PAHC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):